SCHEMBL7174382

SCHEMBL7174382

CCNc1ccccc1-c1cc[c]cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.42
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39
USP2 O75604 2/20 0.39
CASP1 P29466 1/20 0.39
BRCA1 P38398 1/20 0.39
CASP7 P55210 1/20 0.39
MAPT P10636 4/20 0.38
POLB P06746 3/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
IDO1 P14902 1/20 0.37
ALDH1A1 P00352 4/20 0.36
KDM4E B2RXH2 1/20 0.36
HPGD P15428 1/20 0.36
SOAT1 P35610 2/20 0.36
ADRA2C P18825 2/20 0.36
KCNQ2 O43526 1/20 0.36
ADRA2A P08913 1/20 0.36
ADRA2B P18089 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7175448 0.86 PDE5A (0.42) SMN1; SMN2MAPTIDO1ALDH1A1KDM4E
SCHEMBL5904052 0.84 SMN1; SMN2 (0.56) SMN1; SMN2MEN1KMT2AUSP2CASP1
SCHEMBL1168220 0.80 IDO1 (0.52) SMN1; SMN2MEN1KMT2AUSP2CASP1
SCHEMBL9306024 0.79 LMNA (0.46) SMN1; SMN2MEN1KMT2AUSP2CASP1
SCHEMBL7186538 0.79 SMN1; SMN2 (0.40) SMN1; SMN2MEN1KMT2AUSP2MAPT
SCHEMBL18415207 0.78 SMN1; SMN2 (0.46) SMN1; SMN2MEN1KMT2AUSP2CASP1
SCHEMBL3904434 0.78 QPCT (0.49) SMN1; SMN2MEN1KMT2AUSP2CASP1
SCHEMBL9196333 0.78 SLC6A4 (0.44) SMN1; SMN2MEN1KMT2AUSP2CASP1
SCHEMBL27570780 0.77 ALDH1A1 (0.37) SMN1; SMN2MEN1KMT2AMAPTRAB9A
SCHEMBL7770001 0.77 STAT3 (0.48) SMN1; SMN2MEN1KMT2AMAPTPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6576664-B1 1-amido-2-hydroxy-substituted-indanes; suppressing production of tumor necrosis factor BRISTOL-MYERS SQUIBB PHARMA COMPANY 2003-06-10 US disclosed